ZEPP SEC Filing News — Zepp Health Corporation

Latest SEC filings for Zepp Health Corporation (ZEPP) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-25.

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health soluti…
Sector: Technology Industry: Consumer Electronics Market Cap: $44.3M CIK: 1720446
8
Total Filings
0
Bullish Classifications
2
Bearish Classifications
3
Insider Transactions
0
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for ZEPP currently lean bearish. Of the 8 filing records displayed, 2 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
ZEPP Filing Activity Snapshot 2025-08-22 — 2026-09-25
Insider Transactions (Form 4)
0 buys vs 2 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$411.1K
Yeung Mike Yan · 2025-09-04
44,000 shares · Form 144
Form 144 Notices
5
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 3 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 3 filings in this group are Form 4s for Zepp Health Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 3 insider filings shown, the breakdown is 2 open-market sale and 1 option exercise. 2 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×2
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Option exercise ×1
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Form 4 Open-market sale Insider Selling 2026-09-25

ZEPP insider Yu Pengtao (Chief Industrial Designer) sold 10,000 shares (~$42.1K)

Yu Pengtao, listed as Chief Industrial Designer at Zepp Health Corp, reported an open-market sale of 10,000 ZEPP shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,749 $4.30 $24.7K
S Open-market sale 4,251 $4.09 $17.4K
Filing: Form 4 (Insider Transaction) Insider: Yu Pengtao (Chief Industrial Designer) Shares: 10,000 Est. Value: $42.1K
Form 4 Option exercise Tax / Compensation Filing 2026-06-30

ZEPP insider Form 4 filed for equity award, exercise, or tax withholding

FAN Meihui (Chief Technology Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 520,000 — —
M Option exercise derivative · Options (right to buy) 160,000 — —
M Option exercise derivative · Options (right to buy) 200,000 — —
M Option exercise derivative · Options (right to buy) 80,000 — —
M Option exercise derivative · Options (right to buy) 80,000 — —
Filing: Form 4 (Insider Transaction) Insider: FAN Meihui (Chief Technology Officer) Shares: 520,000
Form 4 Open-market sale Insider Selling 2026-06-29

ZEPP insider Deng Cheng (Chief Financial Officer) sold 9,836 shares (~$45.3K)

Deng Cheng, listed as Chief Financial Officer at Zepp Health Corp, reported an open-market sale of 9,836 ZEPP shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 22,875 — —
S Open-market sale 9,836 $4.61 $45.3K
A Compensation award derivative · Restricted Share Units 366,000 — —
M Option exercise derivative · Restricted Share Units 366,000 — —
Filing: Form 4 (Insider Transaction) Insider: Deng Cheng (Chief Financial Officer) Shares: 9,836 Est. Value: $45.3K
Proposed Insider Sales 5 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Zepp Health Corporation has 5 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-23

ZEPP Form 144 filed for proposed insider sale by Yu Pengtao (20,000 shares) ~$86.6K

Yu Pengtao filed a Form 144 with the SEC indicating intent to sell ZEPP (Zepp Health Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Yu Pengtao Shares: 20,000 Est. Value: $86.6K
Form 144 Proposed Insider Sale 2026-06-26

ZEPP Form 144 filed for proposed insider sale by Deng Cheng (9,836 shares) ~$47.6K

Deng Cheng filed a Form 144 with the SEC indicating intent to sell ZEPP (Zepp Health Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Deng Cheng Shares: 9,836 Est. Value: $47.6K
Form 144 Proposed Insider Sale 2025-09-29

ZEPP Form 144 filed for proposed insider sale by FAN Meihui (3,000 shares) ~$133.6K

FAN Meihui filed a Form 144 with the SEC indicating intent to sell ZEPP (Zepp Health Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: FAN Meihui Shares: 3,000 Est. Value: $133.6K
Form 144 Proposed Insider Sale 2025-09-04

ZEPP Form 144 filed for proposed insider sale by Yeung Mike Yan (44,000 shares) ~$411.1K

Yeung Mike Yan filed a Form 144 with the SEC indicating intent to sell ZEPP (Zepp Health Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Yeung Mike Yan Shares: 44,000 Est. Value: $411.1K
Form 144 Proposed Insider Sale 2025-08-22

ZEPP Form 144 filed for proposed insider sale by Lai Jimmy Y. (1,745 shares) ~$60.7K

Lai Jimmy Y. filed a Form 144 with the SEC indicating intent to sell ZEPP (Zepp Health Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Lai Jimmy Y. Shares: 1,745 Est. Value: $60.7K

How we classify Zepp Health Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on ZEPP. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — ZEPP SEC Filings

More Tools for ZEPP

Want deeper ZEPP analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the ZEPP stock analysis page.

ZEPP Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer